Predictive toxicology is a pivotal branch of pharmacology that employs advanced scientific techniques to anticipate and assess potential adverse effects of chemical compounds on living organisms. By leveraging computational models, bioinformatics, and high-throughput screening methods, predictive toxicology aims to streamline drug development processes and enhance safety assessments. This interdisciplinary approach integrates data from diverse sources, including genomics, proteomics, and metabolomics, to predict the toxicological profile of substances in a more accurate and efficient manner. This proactive strategy not only accelerates the identification of promising drug candidates but also aids in the design of safer and more effective therapeutic agents. The integration of predictive toxicology into pharmacological research fosters a more comprehensive understanding of the intricate relationship between drug compounds and biological systems, ultimately leading to improved drug safety profiles and reduced instances of unexpected toxic reactions in clinical settings. As predictive toxicology continues to evolve, its contributions to precision medicine and personalized treatment strategies are becoming increasingly evident, paving the way for a future where pharmaceutical interventions are not only effective but also tailored to individual genetic and physiological profiles.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico